Cabtreo: A Three-Drug Gel for Acne
The Medical Letter on Drugs and Therapeutics · 2024
DOI: 10.58347/tml.2024.1700b ↗Kurz gefasst
Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2024. Hauptthemen laut MEDLINE: Acne Vulgaris, Dermatologic Agents.
Abstract (Originalsprache)
The FDA has approved Cabtreo (Bausch Health), a gel containing the retinoid adapalene, the oxidizing agent benzoyl peroxide, and the antibiotic clindamycin, for treatment of acne vulgaris in patients ≥12 years old. Cabtreo is the first three-drug topical formulation to become available in the US for treatment of acne.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
(2024). Cabtreo: A Three-Drug Gel for Acne. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2024.1700b
Vancouver
Cabtreo: A Three-Drug Gel for Acne. The Medical Letter on Drugs and Therapeutics. 2024. doi:10.58347/tml.2024.1700b
BibTeX
@article{euvimed2024,
title = {Cabtreo: A Three-Drug Gel for Acne},
journal = {The Medical Letter on Drugs and Therapeutics},
year = {2024},
doi = {10.58347/tml.2024.1700b}
}
EUVIMED